Scholarly Index
Kenneth S. Koblan
Sumitomo Dainippon Pharma (United States); 6,392 total citations; 167 total publications; best world rank #287
Sumitomo Dainippon Pharma (United States)
6,392Total citations
167Total publications
45H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diffusion and Search Dynamics | Lifetime | 808 | US 208 | 68.40 |
| Receptor Mechanisms and Signaling | 2021-2025 | 287 | US 98 | 90.74 |
| Schizophrenia research and treatment | 2021-2025 | 648 | US 141 | 89.51 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 352 | US 177 | 86.89 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 598 | US 96 | 60.74 |